Patient Lifestyle

There is no better way to ensure patient care transparency and the communication of important information than to work collaboratively with our healthcare provider partners.

US Food and Drug Administration requires warning about GBS be added to the prescribing information for Shingrix (herpes zoster vaccine)

Alberta has become the third province in Canada to fund the Fluzone High-Dose influenza vaccine for all adults aged 65 and older, beginning with 2021-2022 season.

The treatment would be the first to address the underlying genetic defect in children belonging to this younger age group.